There’s Now an FDA-approved App to Treat Depression

The FDA has approved the first app for treating major depressive disorder, a condition estimated to impact 21% of U.S. adults at some point in their lifetime. The app, Rejoyn, is intended to supplement treatment for major depressive disorder: In a...

April 13, 2024

News

Brain stimulation tech wins €5M to fight depression at home

Depression affects approximately 280 million people all over the world, and disproportionately affects the female population — it is 50% more common in women than men. Treatments range from psychotherapy and lifestyle adjustments to antidepressants and more experimental concepts: brain...

March 12, 2024

Sertraline only works for 1 in 3 depression patients, AI study finds

News

Sertraline only works for 1 in 3 depression patients, AI study finds

An AI analysis of people on sertraline found that the popular antidepressant would only work on one-third of patients. The findings, which were published this week in the American Journal of Psychiatry, offer hope for better treatment of depression. By applying...

February 8, 2024